Please login to the form below
lobbying
This page shows the latest lobbying news and features for those working in and with pharma, biotech and healthcare.
Another setback on pricing as Trump drops rebate plans
It is reported that Trump scrapped the idea because he was concerned it could lead to rising health insurance premiums for older people, amid criticism from over-50s lobbying group the
Latest news
-
European elections: Eurosceptics and Greens rise, but big parties hold on
EU-watchers say the industry should be wary of the new influx of Green party MEPs, who have traditionally been strongly suspicious of pharma lobbying and its profit motive.
-
Novartis and Sanofi heads take on UK pharma leadership roles
The ABPI and its biotech counterpart the BIA have been careful to avoid criticising the Government's tactics, however, but will be lobbying hard in private for as soft a Brexit
-
CEOs agree to Congressional grilling on US drug prices
It was considered in the previous Congress but failed to become law, thanks in part to intensive lobbying against it by industry organisation PhRMA.
-
UK patient activist group takes aim at Orkambi patent
The group and others such as #OrkambiNow have mobilised support via social media, including a message from David Mitchell and Patients for Affordable Drugs, which is using the same lobbying tactics
-
UK and EU’s future relationship ‘must protect patients’
And there are now reports that some EU27 countries are lobbying to harden the Brexit conditions further, which could further jeopardise the process. ... The BBC says France and Spain are lobbying the EU over fishing rights in UK waters and the status of
More from news
Approximately 2 fully matching, plus 84 partially matching documents found.
Latest Intelligence
-
The power of the patient influencer
They may be advocating for their fellow patients behind the scenes, lobbying NICE for access to medicines, or publicising fundraising efforts via their local media.
-
The role of women in science and technology
The proactive ones that are determined to help fix things try to do their bit through school outreach work and lobbying to help tackle the issues around science education.
-
Building European biotech firms to rival those of the US
the ABPI and BIA are lobbying hard to preserve links with the EU.
-
It’s not the end of the world, is it?
This exceptional situation has many causes, both proximate and ultimate, ranging from lobbying and political funding to the US political and social culture, which is rooted in its history.
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
International comparisons have always been useful for lobbying purposes. Gone too are reference indicators on the industry more generally, that were called the Pharmaceutical Industry Competitiveness Task Force indications, and which
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Bayer appoints head of EU liaison office
Meanwhile, Halling (pictured left) moves to Bayer's headquarters in Leverkusen to head the company's corporate policy and strategy unit, with responsibility for Bayer's political lobbying positioning.
-
New London head for comms firm JPA
lobbying. “I am excited about building a team in London that will expand JPA's capabilities, broaden our experiences and bring unparalleled service to our clients in the EU,” she said.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: What's missing in women's health?
In light of the recent shortages, women’s health groups are lobbying for a working group to be set up in order to address these supply constraints.
-
Travel in the time of COVID
strains appear, being on the front foot of protecting the world from disease, not waiting for borders to close or – worse – lobbying against.
-
Artificial Intelligence in healthcare
However, Lord Darzi and his colleague Lord Prior are lobbying for increased commitment.
-
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
In light of the fact that the GDPR is changing the healthcare landscape and clinical trial governance, industry leaders may consider advocating or lobbying for inclusion in the future development of
-
Social Media and Health: the Cure or the Disease?
Advocacy groups such as Time Well Spent are lobbying to change the way big tech companies treat their customers.
More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- World Health Organization releases new road map for breast cancer
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Making new year resolutions that can also benefit others
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Bristol Myers Squibb’s plaque psoriasis treatment recommended by CHMP
- Europe’s cancer community publishes new report on transforming patient care
- Assessing the value of interim analyses in clinical trials
- Piloting a route to the biosimilars opportunities in Europe
- Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
